Go to the list of all blogs
Allana's Avatar
published in Blogs
Aug 05, 2026
Why Is Taboola.com (TBLA) Stock Down -26.47% Today?

Why Is Taboola.com (TBLA) Stock Down -26.47% Today?

Key Takeaways

  • TBLA shares plunged 26.47% to approximately $3.89 in midday trading on Wednesday, marking one of the stock's steepest single-day declines since its public debut.
  • Second-quarter earnings missed expectations across the board: revenue of $476.8 million fell short of the $499.4 million consensus, while GAAP EPS of $0.01 badly missed the $0.04 analyst estimate.
  • Q3 revenue guidance of $460–$473 million came in roughly 10% below the $518 million Wall Street consensus, signaling an unexpected contraction in the top line.
  • Full-year revenue guidance was slashed to a midpoint of $1.94 billion from a prior $2.03 billion, though the company raised its adjusted EBITDA outlook.
  • The selloff was entirely company-specific, occurring on a day when the Dow and S&P 500 traded at record highs and the broader communication services sector advanced.
  • Traders are now focused on whether new products like Realize and DeeperDive can offset the revenue headwinds from publisher cleanup and Google policy changes.

Opening Summary

TBLA — Taboola.com Ltd., the digital advertising and content recommendation platform that powers the "You May Also Like" widgets across thousands of publisher websites — saw its stock crater on Wednesday after reporting second-quarter 2026 results that fell short of Wall Street expectations and issuing forward guidance that stunned investors. Shares tumbled approximately 26.47% to $3.89 as of early afternoon trading, down sharply from Tuesday's closing price of $5.29. The decline pushed the stock toward the lower end of its 52-week range of $2.84 to $5.71, wiping out months of accumulated gains in a single session.

Q2 Earnings Miss Sparks the Selloff

The primary catalyst behind today's dramatic selloff was Taboola's second-quarter earnings report, released before the market opened. The company posted revenue of $476.8 million, representing year-over-year growth of just 2.4% and missing the analyst consensus of $499.4 million by approximately 4.5%. On the bottom line, GAAP earnings came in at $0.01 per share, well below the $0.04 that analysts had projected. While Taboola did swing to a net profit of $4.3 million from a net loss of $4.3 million a year earlier, the headline numbers clearly disappointed.

Management attributed the revenue shortfall to two deliberate strategic actions. First, the company undertook a cleanup of lower-quality publishers from its network, which reduced near-term ad inventory but is intended to improve monetization quality over time. Second, and more significantly, the faster-than-expected deprecation of the Explore More product — triggered by a Google policy change — stripped out a meaningful revenue stream during the quarter. The company noted that less than 5% of U.S. page views come from Google search traffic, limiting broader exposure, but the Explore More headwind proved larger than anticipated.

Weak Forward Guidance Stuns the Market

While the quarterly miss was notable, it was Taboola's forward outlook that truly rattled investors. The company guided for third-quarter revenue in the range of $460 million to $473 million — well below the Street consensus of approximately $518 million and implying a year-over-year revenue decline of roughly 5% to 7%. This marks a sharp reversal after consecutive quarters of growth.

For the full year, Taboola cut its revenue guidance to a range of $1.93 billion to $1.96 billion, down from its prior forecast of $2.006 billion to $2.062 billion. The new midpoint of $1.94 billion represents a cut of roughly $91 million and sits well below the $2.04 billion that analysts had been modeling. The magnitude of the guidance reduction signaled to investors that the headwinds from the publisher cleanup and Google-related product changes would persist longer than previously expected.

Profitability Bright Spots Overshadowed

Not all of the quarterly report was negative. Taboola posted several profitability metrics that actually exceeded expectations. Ex-TAC gross profit — which strips out traffic acquisition costs — rose 11.8% year over year to $192.4 million, beating the company's own guidance range. Adjusted EBITDA surged 22.8% to $55.5 million, with margins expanding to 28.8% from 26.2% a year ago. The company also raised its full-year adjusted EBITDA guidance to a range of $228 million to $240 million and lifted its ex-TAC gross profit outlook.

However, investors also noted that free cash flow declined sharply to $17.3 million from $34.2 million in the prior-year quarter, and operating cash flow fell to $31.3 million from $47.4 million. The divergence between adjusted profitability metrics and actual cash generation added another layer of concern. The market's reaction made clear that, for today at least, the revenue trajectory matters more than margin improvement.

Market Context and Trading Activity

The selloff in TBLA was notable for its severity and for the fact that it occurred in isolation. On Tuesday, the Dow Jones Industrial Average and S&P 500 both closed at record highs, while the Nasdaq Composite surged 2.59%. The Communication Services sector, where Taboola resides, was among the day's strongest performers. Wednesday's session opened with major indices again pushing into record territory. This broader strength underscores that Taboola's decline was driven entirely by company-specific factors rather than macro or sector weakness.

Trading volume in TBLA was heavy throughout the session, running well above the stock's average daily volume of roughly 3 million shares, reflecting intense institutional repositioning following the earnings disappointment. The stock breached key technical support levels, including its 50-day moving average, and approached the lower end of its 52-week range. With short interest at approximately 2–3% of the float prior to the report, the selloff did not appear to be driven by a short squeeze but rather by genuine long-side liquidation.

What Comes Next for TBLA

Looking ahead, Taboola's management struck an optimistic tone on the earnings call, emphasizing that new AI-driven products — including Realize, Realize+, and DeeperDive (which is reportedly nearing 10 million daily active users) — are building momentum and should contribute more meaningfully in late 2026 and into 2027. The recent addition of Fox News as a publishing partner was cited as a strategic win that strengthens the platform's premium inventory. Analysts remain divided: price targets from firms including Needham, TD Cowen, Benchmark, and Rosenblatt ranged from $5.50 to $7.00 in recent months — all well above where the stock is trading today — but those targets will almost certainly face downward revisions after this report.

Key risks include the ongoing transition away from legacy native advertising toward full-page AI-driven monetization, the potential for additional Google policy changes, and the execution risk around integrating new publisher partnerships. For the stock to stabilize, investors will need to see evidence in the coming quarters that the revenue deceleration is temporary and that the profitability gains are sustainable.

Trending AI Robots

In volatile market environments like the one affecting TBLA today, traders increasingly turn to automated strategies to navigate sharp price swings. Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots that have demonstrated strong performance under current market conditions. With hundreds of bots covering thousands of tickers across different strategies, timeframes, and performance metrics, the platform highlights only those that are leading the pack right now. Each bot varies by trading style — from swing trading to trend following — giving traders a range of approaches to explore. Visit the Trending AI Robots page to discover which AI strategies are currently outperforming.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TBLA

TBLA sees its Stochastic Oscillator climbs out of oversold territory

On July 29, 2026, the Stochastic Oscillator for TBLA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 57 instances where the indicator left the oversold zone. In of the 57 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 04, 2026. You may want to consider a long position or call options on TBLA as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

TBLA moved above its 50-day moving average on July 28, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TBLA advanced for three days, in of 253 cases, the price rose further within the following month. The odds of a continued upward trend are .

TBLA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for TBLA moved out of overbought territory on July 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for TBLA turned negative on July 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TBLA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TBLA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.516) is normal, around the industry mean (5.707). P/E Ratio (14.722) is within average values for comparable stocks, (34.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (32.438). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.830) is also within normal values, averaging (71.599).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TBLA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Meta Platforms (NASDAQ:META), Spotify Technology SA (NYSE:SPOT), Nebius Group N.V. (NASDAQ:NBIS), Baidu (NASDAQ:BIDU), Tencent Music Entertainment Group (NYSE:TME), Pinterest (NYSE:PINS), Snap (NYSE:SNAP), Zillow Group (NASDAQ:Z).

Industry description

Companies in this industry typically license software on a subscription basis and it is centrally hosted. Such products usually go by the names web-based software, on-demand software and hosted software. Cloud computing has emerged as a major force in this space, making it possible to save files to a remote database (without requiring them to be saved on local storage device); as long as a device has access to the web, it can access the data and the software programs to run it. This has in many cases facilitated cost efficiency, speed and security of data for businesses and consumers. Alphabet Inc., Facebook, Inc. and Yahoo! Inc. are some well-known names in the internet software/services industry.

Market Cap

The average market capitalization across the Internet Software/Services Industry is 153.64B. The market cap for tickers in the group ranges from 2.69K to 4.61T. GOOGL holds the highest valuation in this group at 4.61T. The lowest valued company is STBXF at 2.69K.

High and low price notable news

The average weekly price growth across all stocks in the Internet Software/Services Industry was 3%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -3%. AREN experienced the highest price growth at 47%, while ONFO experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Internet Software/Services Industry was -13%. For the same stocks of the Industry, the average monthly volume growth was 49% and the average quarterly volume growth was -59%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 71
Price Growth Rating: 59
SMR Rating: 79
Profit Risk Rating: 94
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
TBLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry InternetSoftwareServices

Profile
Details
Industry
N/A
Address
16 Madison Square West
Phone
+1 212 206-7633
Employees
1900
Web
https://www.taboola.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.